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Cardiomyopathy
• a condition primarily nvolving the myocardium
• not the result of congenital, acquired valvular, 
hypertensive, coronary arterial, or pericardial 
abnormalities
• 2 forms:
– Primary type
– Secondary type
Primary cardiomyopathy
• consisting of heart muscle disease 
predominantly involving the myocardium 
and/or of unknown cause
Secondary cardiomyopathy
• consisting of myocardial disease of known 
cause or associated with a systemic disease 
such as amyloidosis or chronic alcohol use (
three morphologic types 
• dilated, restrictive, and hypertrophic
three morphologic types 
• 1. Dilated: Left and/or right ventricular 
enlargement, impaired systolic function, 
congestive heart failure, arrhythmias, emboli
• 2. Restrictive: Endomyocardial scarring or 
myocardial infiltration resulting in restriction to 
left and/or right ventricular filling
• 3. Hypertrophic: Disproportionate left ventricular 
hypertrophy, typically involving septum more 
than free wall, with or without an intraventricular
systolic pressure gradient; usually of a nondilated
left ventricular cavity
Dilated cardiomyopathy
• 1/3 of all cases
• LV and/or right ventricular (RV) systolic pump 
function is impaired, leading to progressive 
cardiac dilatation (remodeling)
• Symptoms of heart failure (HF) typically appear 
only after remodeling has been ongoing for some 
time (months or even years)
Dilated cardiomyopathy
• In most cases, no cause is apparent
• Familial
• end result of myocardial damage 
• may be the late consequence of acute viral 
myocarditis
• most commonly becomes apparent clinically 
in the third or fourth decades
• reversible form of DCM may be found with 
alcohol abuse, thyroid disease, cocaine use 
and chronic uncontrolled tachycardia
Dilated cardiomyopathy
CLINICAL FEATURES
• Symptoms of left- and right-sided CHF usually 
develop gradually 
• vague chest pain may be present
• Syncope due to arrhythmias and systemic 
embolism (often emanating from a ventricular 
thrombus) may occur
Dilated cardiomyopathy
PHYSICAL EXAMINATION
• Variable degrees of cardiac enlargement 
• findings of Congestive heart failure
• rales, edema
• pulse pressure is narrow 
• jugular venous pressure is elevated
Dilated cardiomyopathy
LABORATORY
• Chest Xray
– enlargement of the cardiac silhouette due to LV 
dilatation
– pulmonary vascular redistribution 
– alveolar edema
• ECG
– Sinus tachycardia,atrial fibrillation, ventricular 
arrhythmias, left atrial abnormality, low voltage
Treatment
• Most patients die within 4 years
• ¼ have spontaneous improvement
• patients should be considered for chronic 
anticoagulation
• Standard therapy for heart failure
• Alcohol should be avoided  - cardiotoxic
effects 
Hypertrophic cardiomyopathy
• characterized by LV hypertrophy, typically of a 
nondilated chamber, without obvious cause
• 1 in 500 of the general population
• pathophysiologic abnormality is diastolic
dysfunction
Hypertrophic cardiomyopathy
• majority demonstrate a ventricular septum 
whose thickness is disproportionately 
increased when compared with the free wall
• half of all patients with HCM have a positive 
family history 
• genetic testing may allow a definitive 
diagnosis of HCM 
Hypertrophic cardiomyopathy
CLINICAL FEATURES
• Variable
• asymptomatic or mildly symptomatic 
• first clinical manifestation may be SCD 
(sudden cardiac death)
• occurring in children and young adults during or after 
physical exertion
• most common cause of SCD in young competitive 
athletes
Hypertrophic cardiomyopathy
PHYSICAL EXAMINATION
• hallmark of obstructive HCM is a systolic 
murmur, which is typically harsh, diamond-
shaped, and usually begins well after the first 
heart sound
Hypertrophic cardiomyopathy
LABORATORY
• ECG:
• LV hypertrophy and widespread deep, broad Q waves
• Chest Xray
• May be normal or mild increase in silhouette
• Echocardiogram
• Mainstay in diagnosis
• LV hypertrophy, often with the septum 1.3 times the 
thickness of the posterior LV free wall
Hypertrophic Cardiomyopathy
TREATMENT
• Dehydration avoided
• Diuretics used in caution
• Amiodarone appears to be effective in 
reducing the frequency of supraventricular as 
well as of life-threatening ventricular 
arrhythmias
Restrictive Cardiomyopathy
• abnormal diastolic function 
• walls are excessively rigid and impede ventricular 
filling
• Myocardial involvement with amyloid is a 
common cause of secondary restrictive 
cardiomyopathy
• transplanted heart, in hemochromatosis, 
glycogen deposition, endomyocardial fibrosis, 
sarcoidosis, hypereosinophilic disease, and 
scleroderma
Restrictive Cardiomyopathy
CLINICAL FEATURES
– inability of the ventricles to fill limits cardiac 
output and raises filling pressures
– exercise intolerance and dyspnea
– dependent edema, ascites, and an enlarged, 
tender, and often pulsatile liver
– heart sounds may be distant, and third and fourth 
heart sounds are common
Restrictive Cardiomyopathy
LABORATORY
• ECG 
– low-voltage, nonspecific ST-T-wave abnormalities 
and various arrhythmias
• Echocardiography, CTI, and CMRI 
– symmetrically thickened LV walls and normal or 
slightly reduced ventricular volumes and systolic 
function
